Autonomic Technologies, Inc. (ATI) is a medical device company located in the San Francisco Bay Area focused on the development of neurostimulators for the treatment of severe headache. The company’s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache and is currently being investigated in a multi-center, randomized study for the treatment of high frequency, high disability migraine.
The ATI Neurostimulation System is a rechargeable, multi-channel, peripheral nerve stimulation system. The System includes:
- The ATI Neurostimulator: A miniaturized neurostimulator (smaller than an almond) with an integral lead designed to fit ranging facial anatomy.
- The Remote Controller: A hand-held device with simple therapy controls that provides on-demand patient-controlled SPG therapy. Therapy settings are individualized and can be adjusted quickly by physicians using a programmer laptop.